Page last updated: 2024-08-23

paclitaxel and Adenoma, Hepatocellular

paclitaxel has been researched along with Adenoma, Hepatocellular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, HG; Choi, JY; Choi, Y; Kim, J; Kwang Ku, S; Oh Kim, J; Poudal, BK; Ramasamy, T; Ruttala, HB; Soon Yong, C	1

Other Studies

1 other study(ies) available for paclitaxel and Adenoma, Hepatocellular

Article	Year
Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy. Oncotarget, 2017, Feb-28, Volume: 8, Issue:9 Topics: Adenoma, Liver Cell; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lipids; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays	2017

Article

Year

Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.

Oncotarget, 2017, Feb-28, Volume: 8, Issue:9

Topics: Adenoma, Liver Cell; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lipids; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Paclitaxel; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays

2017